SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Greater China Junior Stocks

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Julius Wong who wrote (907)8/25/2005 1:42:03 AM
From: tsigprofit  Read Replies (1) of 1992
 
Julius - any idea what Chinese biotech $ 2 stock traded on an American exchange they may be referring to here?? - thanks:

Scientists have recently discovered a new, ultra-contagious "super-flu" that is impervious to any known treatment. No human being has a proven immunity to this disease. This nasty virus has wiped out 72% of the known human cases infected with it. Medical specialists consider this the greatest threat facing the world today. This is one bad bug!

But this minuscule company is coming to the rescue again. It's in a unique partnership with the Chinese CDC and is solving the problem. Potential gains? In an epidemic situation, think 6 billion people at $10 a dose.

That kind of revenue for a tiny company like this one could easily propel its price Up to 90 Times in Value!

Venture Capitalist-Style Returns

The best news? This Chinese biotech company is available on a U.S. stock exchange for right around two bucks and change. When it's all said and done, this stock could turn every $1,000 into $90,000.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext